Literature DB >> 23709725

Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.

Kenneth A Bauer1.   

Abstract

Entities:  

Keywords:  apixaban; atrial fibrillation; dabigatran; international normalized ratio; prothrombin time; rivaroxaban; vitamin K antagonists

Mesh：

Substances：

Year:  2013        PMID： 23709725     DOI： 10.1161/STROKEAHA.111.000387

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  3 in total

1.  Patient perspectives of dabigatran: analysis of online discussion forums.

Authors:  Mary S Vaughan Sarrazin; Peter Cram; Alexandur Mazur; Melissa Ward; Heather Schacht Reisinger
Journal:  Patient       Date:  2014       Impact factor: 3.883

2.  The epidemic of pre-injury oral antiplatelet and anticoagulant use.

Authors:  A E Berndtson; R Coimbra
Journal:  Eur J Trauma Emerg Surg       Date:  2014-05-01       Impact factor: 3.693

3.  Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands.

Authors:  Susan Hanemaaijer; Fong Sodihardjo; Annemieke Horikx; Michel Wensing; Peter A G M De Smet; Marcel L Bouvy; Martina Teichert
Journal:  Int J Clin Pharm       Date:  2015-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.